Work

Prognostic validation of six androgen production, uptake, and conversion genes (APUC-6) in the CHAARTED prostate cancer trial.

Year: 2025

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2025.43.16_suppl.5089

Authors: Xiaolei Shi, Amol Shetty, Jarey Wang, Yang Song, Philip Anthony Sutera, Matthew Pierre Deek, Chad Tang, James A. Proudfoot, Elai Davicioni, Paul L. Nguyen, Christopher Sweeney, Ella Boytim, Charles J. Ryan, Emmanuel S. Antonarakis, Justin Hwang, Phuoc T. Tran

Institutions: University of Maryland, Baltimore, Johns Hopkins University, University of Rochester Medicine, Rutgers, The State University of New Jersey, The University of Texas MD Anderson Cancer Center, Veracyte (United States), Brigham and Women's Hospital, The University of Adelaide, University of Minnesota, Memorial Sloan Kettering Cancer Center, Masonic Cancer Center

Language: English

Topic: Prostate Cancer Treatment and Research

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: U.S. Department of Defense, Prostate Cancer Foundation, Movember Foundation

Award: W81XWH-21-1-0296/NOVEL BIOMARKERS TO DIRECT STEREOTACTIC ABLATIVE RADIOTHERAPY IN CASTRATION-SENSITIVE OLIGOMETASTATIC PROSTATE CANCER.

OpenAlex ID: W4410811660

Cites:

Cited by:

Related to: 10